IL4R-Abx decreased the tumor volumes (Figure 7A), tumor weights (Figure 7B), spleen weights or splenomegaly (Figure 7C and S8A), and the number of metastatic tumor nodules in the lungs (Figure 7D and S8B) more efficiently than Abx and Ctrl-Abx given at a similar dose (5 mg/kg body weight) and Abx given at a higher dose (10 mg/kg body weight). The gene discussed is IL4R; the disease is neoplasm.